Historical record - last NADAC effective date: 2/19/2020
Product Information
PIOGLITAZONE-METFORMIN 15-500 is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.7737 per EA under NDC 57237021781. Its NADAC has been published 134 times since Aug 9, 2017.
FDA first approved this application on Feb 13, 2013. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
500; 15 mg/1; mg/1
Manufacturer
Rising Pharma Holdings Inc.NDC
57237021781
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Effective Date
2/19/2020
Active Ingredients
METFORMIN HYDROCHLORIDE; PIOGLITAZONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA200823FDA Approved
2/13/2013
TE Code
AB
On Market Since
2/13/2013
Pharmacological Classes
Price Statistics
The NADAC for PIOGLITAZONE-METFORMIN 15-500 has been published 134 times since Aug 9, 2017, and over the history we have for it it has declined 26.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.7737 per EA |
|---|---|
| All-time high | $1.2349 (Feb 14, 2018) |
| All-time low | $0.7538 (Oct 17, 2018) |
| Median price | $0.9414 |
| Average price | $0.9428 |
| Largest weekly change | +43.5% (Jan 22, 2020) |
| Weeks tracked | 134 |
| Tracking since | Aug 9, 2017 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
-26.2%
Last surveyed Feb 26, 2020 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 58% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of PIOGLITAZONE-METFORMIN 15-500?
The current National Average Drug Acquisition Cost (NADAC) for PIOGLITAZONE-METFORMIN 15-500, manufactured by Rising Pharma Holdings Inc., is $0.7737 per EA (NDC 57237021781), effective Feb 26, 2020.
How has the price of PIOGLITAZONE-METFORMIN 15-500 changed over time?
Over the history we have for it, the NADAC for PIOGLITAZONE-METFORMIN 15-500 has declined 26.2%. It has been tracked across 134 weekly CMS publications since Aug 9, 2017.
What are the highest and lowest recorded NADAC prices for PIOGLITAZONE-METFORMIN 15-500?
Since Aug 9, 2017, the NADAC for PIOGLITAZONE-METFORMIN 15-500 has ranged from a low of $0.7538 (Oct 17, 2018) to a high of $1.2349 (Feb 14, 2018), with a median of $0.9414 per EA.
Are there cheaper alternatives to PIOGLITAZONE-METFORMIN 15-500?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, PIOGLITAZONE-METFORMIN 15-500, is $0.3220 per EA — about 58% below PIOGLITAZONE-METFORMIN 15-500.
Who manufactures PIOGLITAZONE-METFORMIN 15-500?
PIOGLITAZONE-METFORMIN 15-500 (NDC 57237021781) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.